A mutant receptor tyrosine phosphatase, CD148, causes defects in vascular development - Wikidata - awgldk - TriplyDB

A mutant receptor tyrosine phosphatase, CD148, causes defects in vascular development

A mutant receptor tyrosine phosphatase, CD148, causes defects in vascular development

http://www.wikidata.org/entity/Q28508534

about

Contact-inhibited chemotaxis in de novo and sprouting blood-vessel growth Contact inhibition of VEGF-induced proliferation requires vascular endothelial cadherin, beta-catenin, and the phosphatase DEP-1/CD148 Loss of the protein-tyrosine phosphatase DEP-1/PTPRJ drives meningioma cell motility VE-PTP controls blood vessel development by balancing Tie-2 activity Tumor suppressor density-enhanced phosphatase-1 (DEP-1) inhibits the RAS pathway by direct dephosphorylation of ERK1/2 kinases New role for the protein tyrosine phosphatase DEP-1 in Akt activation and endothelial cell survival Regulation of Endothelial Adherens Junctions by Tyrosine Phosphorylation Regulation of cell adhesion by protein-tyrosine phosphatases: II. Cell-cell adhesion Vascular endothelial tyrosine phosphatase (VE-PTP)-null mice undergo vasculogenesis but die embryonically because of defects in angiogenesis Mst1 and mst2 are essential regulators of trophoblast differentiation and placenta morphogenesis G1 checkpoint failure and increased tumor susceptibility in mice lacking the novel p53 target Ptprv Dynamic responses of endothelial cells to changes in blood flow during vascular remodeling of the mouse yolk sac.ALK1 signalling analysis identifies angiogenesis related genes and reveals disparity between TGF-beta and constitutively active receptor induced gene expression A monoclonal antibody against CD148, a receptor-like tyrosine phosphatase, inhibits endothelial-cell growth and angiogenesis Src-mediated post-translational regulation of endoglin stability and function is critical for angiogenesis Expression and function of the protein tyrosine phosphatase receptor J (PTPRJ) in normal mammary epithelial cells and breast tumors.CXM: a new tool for mapping breast cancer risk in the tumor microenvironment.Density enhanced phosphatase-1 down-regulates urokinase receptor surface expression in confluent endothelial cells CD45, CD148, and Lyp/Pep: critical phosphatases regulating Src family kinase signaling networks in immune cells Cancer susceptibility in the mouse: genetics, biology and implications for human cancer.Syndecan-2 is a novel ligand for the protein tyrosine phosphatase receptor CD148 Thrombospondin-1 acts as a ligand for CD148 tyrosine phosphatase.Exome sequencing reveals genetic differentiation due to high-altitude adaptation in the Tibetan cashmere goat (Capra hircus).De Novo and Rare Variants at Multiple Loci Support the Oligogenic Origins of Atrioventricular Septal Heart Defects.Receptor type protein tyrosine phosphatases (RPTPs) - roles in signal transduction and human disease.Protein-tyrosine phosphatases and cancer.Cell-cell adhesion in lung endothelium.Protein tyrosine phosphatases: functional inferences from mouse models and human diseases.Substrate specificity of R3 receptor-like protein-tyrosine phosphatase subfamily toward receptor protein-tyrosine kinases.Deciphering the functional role of endothelial junctions by using in vivo models Regulation of vascular integrity.Protein tyrosine phosphatases in glioma biology Phosphatase regulation of intercellular junctions.Endothelial cell-to-cell junctions: adhesion and signaling in physiology and pathology.Phosphatases and kinases as regulators of the endothelial barrier function.Modulation of VEGF receptor 2 signaling by protein phosphatases.Protein tyrosine phosphatase hPTPN20a is targeted to sites of actin polymerization.Shed syndecan-2 inhibits angiogenesis Structurally distinct phosphatases CD45 and CD148 both regulate B cell and macrophage immunoreceptor signaling.A truncated kringle domain of human apolipoprotein(a) inhibits the activation of extracellular signal-regulated kinase 1 and 2 through a tyrosine phosphatase-dependent pathway.

P2860

bc0f586a321bf3dec68e84ce40cebbbc8600b159

P248

Q21558516-6C89373D-E64F-4AE4-9A60-F158C0A16AC4 Q24303092-CC7A0FEB-C7E7-4364-A345-732F04A391D6 Q24307712-28BC5DED-FF5C-4900-AEED-027B419660B5 Q24311848-D71A3783-B094-4524-9530-E706EA62215C Q24316361-1D1EADC0-802D-4BE6-A12D-B74699BF4988 Q24336075-41707E4E-A921-49A8-9D62-577BF6727DCB Q26778080-47EE392B-A4AF-4AAE-B736-E51EE483EBC8 Q28298929-891FFD7E-E9A3-463B-B877-75A4F1864BD2 Q28507817-D8F534E2-97D1-4C3E-8849-1FB281CAAE37 Q28585805-19E74222-E0A6-4E1F-AA79-C25290EF278A Q28588512-994223C6-E499-4D72-B967-D324C8C37581 Q30544920-15F82FEF-2AD3-41E6-A290-91E3E7FA7AD9 Q30811602-C0480063-A783-40A7-A6E2-6900046C73DF Q33239027-5CEAB9FE-F375-4527-8023-02675397F10D Q34170622-56D28B80-DB6F-4491-BCDC-86A0E750359B Q34345106-EAA5F841-8CA1-48B1-AB43-5A6E6A2A98C1 Q34586307-7516CB90-5A5D-4F28-B653-30E840005805 Q34924478-C6DDB08C-9CCB-49C4-A2FE-0B7052FD42DB Q34963679-3DEEADE7-EAC0-469D-8785-785949F9C9F7 Q35209979-2062DCE6-6973-4294-B42B-A07C545C5FB4 Q35241542-3591A975-BB9B-43EC-8B23-59B7F760FF40 Q35750930-67DFF7A6-61F4-4A29-8C20-107E03BF4EAD Q35927843-0E924FE1-CC69-4216-B518-841203A20779 Q35983745-0B0800C1-5712-4D6C-82E7-91E80A14019F Q36170039-36AFF5A5-FDE5-4D16-9281-2E96E594E394 Q36430193-7FDB59F6-6D2B-460D-9CE0-5F4112D1E0EE Q36645364-297B19C7-1194-42E6-9C93-C479A0B64FA0 Q37094061-4327F9CB-468E-4F6F-99EF-E1A1215F5DA9 Q37095466-3EF12B7D-7F1D-45CF-A734-678D9AEEB179 Q37207003-F4C63165-4F2A-4E54-8802-970516155729 Q37428915-D08BF65E-2EDC-4E58-861A-0D51736BF89E Q37638344-9CD494BD-0262-48E6-995D-EC1C19BBD944 Q37728541-2C6AE9C7-4A34-4341-975E-1FEB5E5CE1FF Q38048760-E76B6C68-9A8D-42C1-882C-3A79DEA14441 Q38190833-8B1714B8-A687-4BA6-BEBC-9C770AA63D74 Q39020269-12FDD197-C276-47E6-B2E4-C9DE7A416A39 Q40442779-D0F378C1-BD45-447D-A144-CF0629D650F6 Q41984948-370AF246-6127-46E0-973B-344943281547 Q43072360-F601E399-AA99-47C3-B22E-A97DC01A8B46 Q44783961-DA8A1410-A0C8-4FE8-8AF8-12B8DD599957

P2860

A mutant receptor tyrosine phosphatase, CD148, causes defects in vascular development

http://www.wikidata.org/entity/Q28508534

description

2003 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի մարտին հրատարակված գիտական հոդված

@hy

artículu científicu espublizáu en 2003

@ast

im März 2003 veröffentlichter wissenschaftlicher Artikel

@de

scientific journal article

@en

vedecký článok (publikovaný 2003/03/01)

@sk

vědecký článek publikovaný v roce 2003

@cs

wetenschappelijk artikel (gepubliceerd op 2003/03/01)

@nl

наукова стаття, опублікована в березні 2003

@uk

مقالة علمية (نشرت في مارس 2003)

@ar

name

A mutant receptor tyrosine phosphatase, CD148, causes defects in vascular development

@ast

A mutant receptor tyrosine phosphatase, CD148, causes defects in vascular development

@en

A mutant receptor tyrosine phosphatase, CD148, causes defects in vascular development

@nl

type

label

A mutant receptor tyrosine phosphatase, CD148, causes defects in vascular development

@ast

A mutant receptor tyrosine phosphatase, CD148, causes defects in vascular development

@en

A mutant receptor tyrosine phosphatase, CD148, causes defects in vascular development

@nl

prefLabel

A mutant receptor tyrosine phosphatase, CD148, causes defects in vascular development

@ast

A mutant receptor tyrosine phosphatase, CD148, causes defects in vascular development

@en

A mutant receptor tyrosine phosphatase, CD148, causes defects in vascular development

@nl

P1433

Q28508534-B7C3581F-C1F3-4D7C-8127-02E2978BB142

P1476

Q28508534-F828AB47-9B89-4F60-8433-9872DD0D65E7

P2093

Q28508534-18E347E0-FE0C-4840-96CC-BBAF49256991

Q28508534-2232B5DE-37F1-47B7-8DD9-FDC8166C2E3D

Q28508534-2BCD9AAA-961B-4BAF-8EFB-4D98B7494435

Q28508534-364BAF09-8759-4B12-B68E-1F9909F2DDA3

Q28508534-3A6455EC-15BF-4953-870D-E2198C1BA733

Q28508534-4957A609-3F1A-49FC-95F5-C5AD41CAB962

Q28508534-AC1463A7-F190-47CD-84D2-DB8CAACCA4D2

Q28508534-B71778FB-99F4-4391-A590-79DEBD1E6D2D

Q28508534-D37E6E7C-E70A-47A5-8157-A3E7484D7AB9

Q28508534-F2A2E07E-41E2-4D87-BE45-4AF9395DB3FC

P2860

Q28508534-06B509C4-B2DD-45BE-BA85-D928AAD7B0B2

Q28508534-09E5DAC2-2B07-42AC-9497-3C79C098C5B5

Q28508534-0FFE19F0-9B32-4AF0-B941-75C1435386FF

Q28508534-138D3F37-83FF-4CE2-85EE-E26B973C5A4C

Q28508534-171C9802-255E-4304-95E7-8181AB1D05F2

Q28508534-1F49E6CA-B1AF-44CC-A891-55C3203E65EA

Q28508534-22902DA0-6292-4106-A953-695D75A2CC9B

Q28508534-28227026-BE38-4319-9006-236B1FE8081D

Q28508534-2E9595A0-A3AB-407E-8811-ECF6B26CCC2E

Q28508534-32704B27-65AE-4231-BA38-D04984239DE6

P304

Q28508534-5518FE86-FD23-4484-9CB1-F83953A84707

P31

Q28508534-9F267AA4-D60B-4613-ADB5-7ADFA22A1458

P3181

Q28508534-08939D68-41A3-4BE0-BF0C-CFD368E6DD89

P356

Q28508534-C687418D-A59C-4330-AA3E-5A1E0145ACE9

P407

Q28508534-1BA488AC-5EBF-4C11-B0AC-317C9520FDB2

P433

Q28508534-0E0B4B90-7494-4F75-A45F-9E9B97E20D83

P478

Q28508534-F8205960-41EE-4F00-B3F1-907B8AD28915

P577

Q28508534-006A35A4-B566-4469-B45B-19947C44E6BA

P698

Q28508534-BA0B504B-0F4C-40A9-8E83-B8310DDDD9C1

P921

Q28508534-6A584554-64FF-478C-880E-3A1E76C86878

P932

Q28508534-C111A27D-051E-4810-AD97-A817585A9684

P3181

P356

MCB.23.5.1817-1831.2003

P1433

Molecular and Cellular Biology

P1476

A mutant receptor tyrosine phosphatase, CD148, causes defects in vascular development

@en

P2093

Christopher J. Drake

http://www.w3.org/2001/XMLSchema#string

Dale R. Abrahamson

http://www.w3.org/2001/XMLSchema#string

Keiko Takahashi

http://www.w3.org/2001/XMLSchema#string

Patricia L. St John

http://www.w3.org/2001/XMLSchema#string

Paul A. Fleming

http://www.w3.org/2001/XMLSchema#string

Takamune Takahashi

http://www.w3.org/2001/XMLSchema#string

Takuji Shirasawa

http://www.w3.org/2001/XMLSchema#string

Takuya Tomemori

http://www.w3.org/2001/XMLSchema#string

Thomas O. Daniel

http://www.w3.org/2001/XMLSchema#string

Toshio Watanabe

http://www.w3.org/2001/XMLSchema#string

P2860

Endoglin is an accessory protein that interacts with the signaling receptor complex of multiple members of the transforming growth factor-beta superfamily

Protein tyrosine phosphatase CD148-mediated inhibition of T-cell receptor signal transduction is associated with reduced LAT and phospholipase Cgamma1 phosphorylation

CD148 is a membrane protein tyrosine phosphatase present in all hematopoietic lineages and is involved in signal transduction on lymphocytes

Expression of DEP-1, a receptor-like protein-tyrosine-phosphatase, is enhanced with increasing cell density

Molecular distinction and angiogenic interaction between embryonic arteries and veins revealed by ephrin-B2 and its receptor Eph-B4

The gene SCL is expressed during early hematopoiesis and encodes a differentiation-related DNA-binding motif

The orphan nuclear receptor COUP-TFII is required for angiogenesis and heart development

Receptor tyrosine phosphatase R-PTP-kappa mediates homophilic binding

Receptor protein tyrosine phosphatase PTPmu associates with cadherins and catenins in vivo

Activin receptor-like kinase 1 modulates transforming growth factor-beta 1 signaling in the regulation of angiogenesis

P304

1817–1831

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2417022

http://www.w3.org/2001/XMLSchema#string

P356

10.1128/MCB.23.5.1817-1831.2003

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

23

http://www.w3.org/2001/XMLSchema#string

P577

2003-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12588999

http://www.w3.org/2001/XMLSchema#string

P921

Protein tyrosine phosphatase, receptor type, J

P932

151692

http://www.w3.org/2001/XMLSchema#string